Exane Derivatives’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $2.08K | Hold |
53
| – | – | ﹤0.01% | 434 |
|
|
2022
Q1 | $1.95K | Hold |
53
| – | – | ﹤0.01% | 752 |
|
|
2021
Q4 | $2.42K | Hold |
53
| – | – | ﹤0.01% | 640 |
|
|
2021
Q3 | $1.89K | Sell |
53
-1,589
| -97% | -$56.8K | ﹤0.01% | 787 |
|
|
2021
Q2 | $30.9K | Hold |
1,642
| – | – | 0.01% | 669 |
|
|
2021
Q1 | $38.2K | Hold |
1,642
| – | – | 0.01% | 521 |
|
|
2020
Q4 | $34.1K | Buy |
+1,642
| New | +$34.1K | 0.01% | 474 |
|